Free Republic 1st Quarter Fundraising Target: $88,000 Receipts & Pledges to-date: $15,180
Woo hoo!! And the first 17% is in!! Thank you all very much!!

Keyword: pharmaceuticals

Brevity: Headers | « Text »
  • Johnson & Johnson tumbles after report says it knew for decades...its baby powder contained asbestos

    12/14/2018 11:27:15 AM PST · by Red Badger · 51 replies ^ | Dec. 14, 2018, 11:12 AM | Rebecca Ungarino
    Johnson & Johnson shares sank 8% Friday after Reuters reported that the pharmaceutical giant knew for decades that its baby powder contained asbestos. Reuters reviewed documents, deposition, and trial testimony from at least 1971 to the early 2000s that it said showed powders and raw talc sometimes tested positively for small traces of asbestos. Furthermore, "company executives, mine managers, scientists, doctors, and lawyers fretted over the problem and how to address it while failing to disclose it to regulators or the public," the Reuters reporter Lisa Girion wrote. Johnson & Johnson issued a statement on Friday in response to the...
  • Fmr Pfizer exec who joined HHS to lower drug prices found bludgeoned to death in DC, Ruled “suicide”

    11/20/2018 6:17:37 AM PST · by deandg99 · 31 replies
    DC Dirty Laundry ^ | 11/20/2018 | Mike Adams
    A former executive for Pfizer, recently tasked with joining HHS to help reduce the prices of Big Pharma’s monopoly prescription medications, was found bludgeoned to death outside his Washington D.C. apartment. Local police ruled the death of Daniel Best a suicide, raising immediate questions about how an individual can bludgeon himself to death with multiple blows. “The city’s Office of the Chief Medical Examiner on Thursday said Best died from “multiple blunt force injuries” and it ruled his death a suicide. It would not release further information,” reports The news website also reports: In announcing his death, HHS Secretary...
  • Trump administration plans to require drug companies to include prices in ads

    10/15/2018 1:49:37 PM PDT · by yesthatjallen · 38 replies
    The Hill ^ | 10/15/18 | JESSIE HELLMANN
    Drug companies would be required to include list prices in advertisements under a Trump administration proposal released Monday. The proposed rule, announced by Health and Human Services Secretary Alex Azar Monday, is the next step in the administration’s efforts to bring down drug prices. "Patients deserve to know what a given drug will cost when they're being told about the benefits and risks it may have," Azar said during a speech Monday in Washington D.C. "And they deserve to know when a drug company has pushed its prices to abusive levels, and they deserve to know this every time they...
  • Tackling Rising Drug Prices in America

    09/06/2018 10:13:18 AM PDT · by Kaslin · 21 replies ^ | September 6, 2018 | Congressman Earl L. “Buddy” Carter
    Before entering public service at the federal level, I spent most of my life serving my community in a different way. As a pharmacist for more than 30 years, I saw firsthand the impact that prescription drug prices have on everyday citizens and families. As a result of research and development I have seen improvements in medications that save lives. Illnesses that were once a death sentence are now treatable with a prescription. While this is nothing short of a miracle, these advances are worthless if they are not affordable. I have seen elderly couples forced to choose between their...
  • President Trump Holds Press Conference & Announces New Grant (Drug Free Coalition Grant)

    08/29/2018 4:39:35 PM PDT · by Freedom'sWorthIt · 8 replies
    Youtube ^ | 8/29/18 | Trump TV Network
    Just another example of good things the President is doing that will be ignored by the LSM. Nice to hear the testimonials included, especially the first gentleman to speak but also the young people who give their testimonials.
  • After a hiring blitz, where is Mustang's CAR-T manufacturing headed? (Bio-Pharma)

    08/17/2018 8:01:48 PM PDT · by 2ndDivisionVet
    Biopharma Dive ^ | August 16, 2018 | Jacob Bell
    Until recently, New York's Mustang Bio has focused its business exclusively on cell therapies. Earlier this week, the biotech announced plans to license an ex vivo lentiviral gene therapy developed at St. Jude Children’s Research Hospital for the treatment of a rare illness known as XSCID, otherwise known as bubble boy disease. The deal underscores what has been a year of growth for Mustang. In June, the company celebrated the opening of a 27,000-square-foot Massachusetts manufacturing plant that executives believe will be able to meet the clinical and commercial supply needs for its investigational CAR-T therapies. BioPharma Dive spoke with...
  • Pharma Is Running Out of Scapegoats for High Drug Prices

    08/17/2018 8:33:01 AM PDT · by Kaslin · 51 replies ^ | August 17, 2018 | Mytheos Holt
    Abusive, monopolistic behavior is never popular: just ask John D. Rockefeller, Cornelius Vanderbilt, or J.P. Morgan. Nor, for that matter, is it sustainable, no matter how many high powered lobbyists you hire to control the debate in Washington, DC. Sooner or later, monopolists back the wrong horse, and someone comes to power who owes them nothing. Just ask President Theodore Roosevelt, and now President Donald Trump.But where Roosevelt famously wrung the life out of the aforementioned tycoons and their trusts, President Trump faces two very different but no less abusive foes: the Snowflake Barons of the tech sector, and the...
  • Senate Moves To Ban Pharmacy ‘Gag Clauses’

    07/25/2018 7:44:15 PM PDT · by E. Pluribus Unum · 19 replies
    One America News Network ^ | UPDATED 1:26 PM PT — Wed. July 25, 2018 | OAN Newsroom
    A Senate committee recently passed a bill allowing pharmacists to inform customers of cheaper prescription options. The new legislation bans the so-called ‘gag clauses’ on contracts between pharmacies and insurers. Such provisions prevent pharmacists from telling customers their prescription is cheaper if paid for with cash instead of using insurance. The Senate bill is sponsored by Republican Senator Susan Collins and is aimed at bringing down health care costs. Collins said the ‘gag clauses’ allowed insurers to increase their revenues by withholding information from customers.
  • How Trump Can Lower Drug Prices

    07/17/2018 8:16:27 AM PDT · by SeekAndFind · 20 replies
    Townhall ^ | 07/17/2018 | Steve Moore
    One of Donald Trump's more memorable promises on the campaign trail was to lower the cost of prescription drugs. Polls show this issue remains popular with Americans, especially lower-income families, who are worried about high drug prices. Of course, the entire concept of drug prices' being "too high" is subjective. Drugs are too expensive ... compared with what? Certainly not compared with not having the drugs available at all. If you suffer from the intense pain of migraine headaches or have been diagnosed with lung cancer, how much would you pay for a drug to help you? I have friends...
  • President Trump Hammers Pharmaceuticals on Twitter

    07/09/2018 10:37:07 AM PDT · by Jeff Chandler · 52 replies
    Twitter ^ | 7-9-2018 | President Donald J Trump
    Pfizer & others should be ashamed that they have raised drug prices for no reason. They are merely taking advantage of the poor & others unable to defend themselves, while at the same time giving bargain basement prices to other countries in Europe & elsewhere. We will respond!
  • Pfizer hikes prices on 100 drugs

    07/04/2018 4:45:05 AM PDT · by DoodleDawg · 47 replies
    The Hill ^ | 7/4/18 | Avery Anapol
    Pharmaceutical giant Pfizer raised prices on about 100 drugs this week, the second round of increases for the company this year. Overall, many of the drugs’ prices have increased by double-digit percentages this year, according to Ars Technica. The Financial Times first reported the price hike. Among the drugs who have seen price hikes are Viagra, the erectile disfunction drug, and Norvasc blood pressure pills. The increased prices come amid heightened focus from lawmakers on drug prices. President Trump has vowed to address high drug costs, and said in May that drug companies would “voluntarily” begin to reduce prices in...
  • Senate to take up Trump's call to lower drug prices 'in June'.....

    05/29/2018 12:35:48 PM PDT · by caww · 13 replies
    www.washingtonexaminer ^ | 5/29/2018 | Robert King
    Sign up for Daily on Healthcare Email Address SUBMIT The Senate plans to start working toward new drug price legislation this summer to help President Trump tackle high prices, even though previous bipartisan measures have struggled to get off the ground. Trump’s blueprint issued a few weeks ago includes several proposal, and senators are planning their own legislation to complement the blueprint. The effort will start next month, when the Senate Health, Education, Labor and Pensions Committee hosts Health and Human Services Secretary Alex Azar on June 12 to discuss the blueprint. Chairman Lamar Alexander, R-Tenn., said ideas for new...
  • Trump denounces ‘middlemen,’ largely spares pharma in drug pricing speech

    05/14/2018 6:05:40 PM PDT · by spintreebob · 23 replies
  • Trump's plan to lower drug prices diverges from campaign promise (barf alert)

    05/12/2018 9:18:38 AM PDT · by gattaca · 19 replies
    New York Slimes ^ | 05/11/2018 | Robert Pear
    President Trump vowed on Friday to “bring soaring drug prices back down to earth” by promoting competition among pharmaceutical companies, and he suggested that the government could require drugmakers to disclose prices in their ubiquitous television advertising. But he dropped the popular and populist proposals of his presidential campaign, opting not to have the federal government directly negotiate lower drug prices for Medicare. And he chose not to allow American consumers to import low-cost medicines from abroad. He would instead give private entities more tools to negotiate better deals on behalf of consumers, insurers and employers.
  • Trump will not call for negotiation on Medicare drug prices despite Democratic hopes

    05/11/2018 5:51:04 AM PDT · by GIdget2004 · 15 replies
    The Hill ^ | 05/10/2018 | Peter Sullivan
    President Trump's drug pricing plan will not include a call for Medicare to negotiate drug prices, a leading Democratic idea that Trump previously supported, a senior administration official said Thursday. “We're not calling for Medicare negotiation in the way that Democrats have called for,” the official said on a call with reporters previewing Trump’s speech on drug prices scheduled Friday. However, the official said there will be other proposals to increase competition in Medicare, likely using private sector players rather than Medicare directly negotiating prices. Democrats have been pressuring Trump ahead of his speech to renew his call for Medicare...
  • HHS secretary: Trump wants to go ‘much, much further’ on tackling drug prices...

    05/09/2018 7:02:11 AM PDT · by caww · 14 replies
    Washington Examiner ^ | 5/9/2018 | Robert King
    Trump’s budget proposal set out several reforms for lowering drug prices, including giving low-income seniors free generic drugs. Azar said the agency wants to solve problems such as the high list prices set by drug makers and “seniors" and government programs overpaying for drugs due to the lack of the latest negotiating tools; rising out-of-pocket costs for consumers; and foreign governments free-riding off American investment in innovation.” Azar also touched on the need for greater transparency of prices of healthcare procedures..........“I believe you ought to have the right to know what a procedure is going to cost, and what it’s...
  • Monday Moanin’ - Gotta’ Nuke Something!

    03/19/2018 7:54:04 AM PDT · by NOBO2012 · 2 replies
    MOTUS A.D. ^ | 3-19-18 | MOTUS
    I understand that some Congressmen (by that I mean men and women, I’m unaware of any other “genders” currently serving but if there are, it includes them too) are offering jobs to Andrew McCabe in order to allow him to earn his federal pension. Would have been nice if they’d been similarly concerned about ordinary Americans who lost their jobs, and pensions, during the 8 year Obama occupation.I wish they’d just get back to tending to Global Warming, so the Rothschilds don’t end up running the world – and the weather.But what’s really not what’s bothering me today; number one...
  • Metformin Diabetes Drug Could Extend Lifespan

    02/17/2017 4:45:58 PM PST · by blam · 40 replies
    Medical News Today ^ | 8-8-2014 | Hannah Nichols
    Metformin is approved in the US as a treatment for type 2 diabetes. A new study by Cardiff University, UK, involving over 180,000 people, reveals that the drug could also increase the lifespan of those individuals who are non-diabetics. According to the Centers for Disease Control and Prevention (CDC), there are around 29.1 million people in the US with diabetes, equating to 9.3% of the population. Type 2 diabetes accounts for 90-95% of diabetes cases and is usually associated with older age, obesity and physical inactivity, family history of type 2 diabetes or a personal history of gestational diabetes. Senior...
  • New Antibiotic for MRSA Infections is Ready for US Clinical Trials

    02/27/2018 9:53:11 AM PST · by nickcarraway · 15 replies
    Labiotech ^ | Alex Dale Alex Dale on 26/02/2018 | Alex Dale Alex Dale on 26/02/2018
    Destiny Pharma’s antibiotic for post-surgical infections will begin its clinical development after the FDA accepted its Investigational New Drug application. Destiny Pharma wants to combat the growing antibiotic resistance crisis by targeting post-surgical Staphylococcus aureus infections like methicillin-resistant Staphylococcus aureus (MRSA). The FDA has accepted an investigational new drug application (IND) for Destiny’s MRSA candidate, XF-73, which will allow the company to complete Phase I and finalize the design of a Phase II trial. XF-73 is a dicationic porphyrin molecule, which is a member of a new class of antibiotics called XF drugs. Interestingly, XF-73 is a nasal gel, which...
  • Trump: 'One of My Greatest Priorities Is to Reduce the Price of Prescription Drugs'

    01/31/2018 2:41:27 AM PST · by markomalley · 65 replies
    CNS News ^ | 1/31/18 | Susan Jones
    Almost a year to the day after meeting with pharmaceutical executives at the White House, President Trump is once again calling for lower prescription drug prices. In his State of the Union speech Tuesday night, he said it's one of his highest priorities for the year ahead: "One of my greatest priorities is to reduce the price of prescription drugs," the president said, drawing sustained applause from Republicans. Turning to the Democrat side of the aisle, Trump gestured for the seated lawmakers to join Republicans in their standing ovation. "In many other countries, these drugs cost far less than what...